BCM Medical Genetics Laboratories announces new 400K custom designed CMA Comprehensive Microarray
The Medical Genetics Laboratories (MGL) at Baylor College of Medicine (BCM) is excited to announce the most comprehensive clinical microarray available to date. The new 400k custom designed CMA Comprehensive Microarray (v9, MGL test code 8665) now targets over 4,900 genes at the exon level. In addition to exon level copy number, this array also includes 60,000 probes used for SNP analysis for the detection of uniparental disomy (UPD) and absence of heterozygosity (AOH). The break down of the new targeted genes added is as follows:
- 41 clinically relevant genes that have been published in the last 24 months
- 742 genes that are available as a clinical test in the GeneTest database
- 804 X-linked genes
- 276 nuclear mitochondrial and candidate genes
- 232 autoimmune genes
- 316 OMIM autosomal dominant morbid genes
- 100 predicted haploinsufficient genes
- 153 genes associated with autism
- 186 candidate genes associated with epilepsy
- 44 genes associated with ADHD
These new genes are in addition to the previously 1,700 targeted genes associated with intellectual disability, seizure disorders, autism, heart defects, etc.
BCM-MGL also continues to offer free parental testing when indicated. The turnaround time for the new CMA-Comprehensive is 14 days.
For more information, please email email@example.com or call 1-800-411-GENE (4363).